Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

People with plantar corns and calluses may have a higher chance of having metabolic syndrome.

Men with androgenetic alopecia may have higher cholesterol and triglycerides.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Young Indians with premature graying often have lower levels of certain nutrients and unhealthy lifestyles.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Higher cholesterol levels increase aggressive prostate cancer risk.

Cadd4 effectively reduces cholesterol levels without side effects.

The rs1128977 gene variant may affect cholesterol and body measurements.

There's no significant link between blood fat levels and male pattern baldness.

Lower LDL-c levels predict higher COVID-19 mortality.

A specific gene variation increases the risk of high uric acid and cholesterol in young Mexican males.

The ABCG2 gene variant increases the risk of high uric acid and cholesterol, especially in overweight or obese young Mexican males.